Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H15HgNO5.Na.HO |
| Molecular Weight | 505.85 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[Na+].COC(C[Hg+])CNC(=O)C1=CC=CC=C1OCC([O-])=O
InChI
InChIKey=WWKZBHGJCDECFG-UHFFFAOYSA-L
InChI=1S/C13H16NO5.Hg.Na.H2O/c1-9(18-2)7-14-13(17)10-5-3-4-6-11(10)19-8-12(15)16;;;/h3-6,9H,1,7-8H2,2H3,(H,14,17)(H,15,16);;;1H2/q;2*+1;/p-2
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C13H15HgNO5 |
| Molecular Weight | 465.85 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/130827
Sources: https://www.ncbi.nlm.nih.gov/pubmed/130827
MERSALYL (Mersal) is an organomercury compound, mercurial diuretics that superseded by safer diuretics such as thiazides, and is hardly used anymore. Due to the idiosyncratic nature of mercury toxicity, the risk of severe disease and sudden death are unpredictable and frequently show no warning signs. Mercurial diuretics cause diuresis by reducing the reabsorption sodium in the ascending loop of Henle, thus causing more water being delivered to the distal convoluted tubule. Unfortunately, earlier physicians misconstrued hallmark symptoms of mercury poisoning such as excessive salivation as signs of mercury's efficacy, including up until the early 1960s when the use of mercurial diuretics was halted in medicine.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006814 Sources: https://www.ncbi.nlm.nih.gov/pubmed/445225 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Mersal Approved UseUnknown |
Doses
| Dose | Population | Adverse events |
|---|---|---|
15 mL multiple, intravenous Dose: 15 mL Route: intravenous Route: multiple Dose: 15 mL Sources: |
unhealthy, 75 |
Other AEs: Bladder discomfort, Restlessness... Other AEs: Bladder discomfort Sources: Restlessness Muscle cramps Dehydration |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Bladder discomfort | 15 mL multiple, intravenous Dose: 15 mL Route: intravenous Route: multiple Dose: 15 mL Sources: |
unhealthy, 75 |
|
| Dehydration | 15 mL multiple, intravenous Dose: 15 mL Route: intravenous Route: multiple Dose: 15 mL Sources: |
unhealthy, 75 |
|
| Muscle cramps | 15 mL multiple, intravenous Dose: 15 mL Route: intravenous Route: multiple Dose: 15 mL Sources: |
unhealthy, 75 |
|
| Restlessness | 15 mL multiple, intravenous Dose: 15 mL Route: intravenous Route: multiple Dose: 15 mL Sources: |
unhealthy, 75 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5849145
mersalyl 2 ml. intramuscularly, over a period of six days
Route of Administration:
Intramuscular
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1850465
Renal cortical slices (about 5 x 5 x 0.5 mm) from New Zealand white rabbits, fed a sodium-deficient rabbit Chow for 2 to 3 weeks, were prepared. Two or three slices were incubated at 37’C for two to three periods of 1 hr each, unless otherwise indicated, in 2 ml of medium that was continuously gassed with 100% 02. The composition of the standard incubation medium was (in mM): NaC1, 145; KC1, 5.5; CaCl2, 2.0; MgCl2, 1.0; glucose, 10; N-2-hydroxyethylenepiperazine-N-2-ethanesulfonic acid, 10. The pH was adjusted to 7.0. The Na+-free and Cl--free medium was prepared by substituting Na+ with K+, and Cl- with isethionate (2-hydroxyethanesulfonate), respectively. The Na+-free modified medium did not contain 2 mM CaCl2 but contained 2 mM EGTA. In this Na+-free, high K+ medium, Ca2+ was found to exert a marked inhibitory effect on renin secretion. Therefore, Ca2+ was excluded from the medium to avoid the complication of the inhibitory effect of Ca2+ on renin secretion superimposed on the stimulatory effect of EA. The first 1-hr incubation in the standard medium served as the control. For subsequent periods, slices were incubated in media containing different ionic compositions or with MERSALYL (10mkM-3mM). In parallel, slices were incubated in the standard medium without test reagents as the time control. At the end of each incubation period, medium was collected and renin activity was determined by radioimmunoassay of angiotensin I generated following incubation of an aliquot of collected medium with plasma of 48-hr nephrectomized rabbits.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:24:09 GMT 2025
by
admin
on
Wed Apr 02 08:24:09 GMT 2025
|
| Record UNII |
5X1IO031V8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C448
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
||
|
WHO-VATC |
QC03BC01
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
||
|
WHO-ATC |
C03BC01
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
207-748-9
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
5X1IO031V8
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
398
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
DB09338
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
6774
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | RxNorm | ||
|
4657
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201330
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
MERSALYL
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
9806195
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
C77560
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
m7241
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB08779MIG
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
100000081713
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
D008634
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY | |||
|
492-18-2
Created by
admin on Wed Apr 02 08:24:09 GMT 2025 , Edited by admin on Wed Apr 02 08:24:09 GMT 2025
|
PRIMARY |